SynAct Pharma AB · OMXSTO:SYNACT

Quantass ApS bought 20,313 SynAct Pharma AB shares (MAR article 19 notification)

Traded Nov 16, 2026 · Filed Nov 18, 2026 · Read by 6ix Nov 18, 2026

On Nov 16, 2026, Quantass ApS (Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)) bought 20,313 SynAct Pharma AB shares at SEK 14.25 for SEK 289K. Filed Nov 18, 2026 (MAR article 19 notification).

Bought
20,313 shares
Price
SEK 14.25
Value
SEK 289K
Role
Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)

The register entry

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026SynAct Pharma ABBuy20,313SEK 14.25Indirect

Source

View original at Finansinspektionen

Related